Laurent Coudeville - infectious disease modeling - Best Researcher Award
SANOFI VACCINES - France
AUTHOR PROFILE
EXPERT IN VACCINE MODELING 🦠
Laurent Coudeville is a Senior Modeling Expert at Sanofi Vaccines, with extensive expertise in infectious disease modeling and advanced analytics. His work focuses on developing strategies for vaccine impact assessment and statistical modeling. Over the years, Laurent has become a key figure in the public health community, influencing the global fight against infectious diseases like COVID-19, Dengue, and Influenza through his research and collaborations.
ECONOMICS AND HEALTHCARE 📊
Laurent holds a PhD in Economics from Claude Bernard University, where he specialized in the diffusion of innovations in healthcare, with a focus on the measles vaccine. His research combines health economics with disease transmission models, allowing him to evaluate the economic impact of vaccination programs and healthcare innovations. He has published over 100 peer-reviewed articles on the subject, shaping policy decisions in health economics.
VACCINE-RELATED RESEARCH 💉
With two decades of experience at Sanofi, Laurent has contributed significantly to the company’s vaccine research. His work covers a broad spectrum of diseases, from Pertussis and Rabies to Meningitis and Hepatitis A. His expertise has supported global efforts to optimize vaccine strategies, enhance public health interventions, and improve disease prevention methods through data-driven insights.
COLLABORATION WITH INSTITUTIONS 🌐
Laurent has partnered with renowned academic institutions worldwide, including Imperial College London, John Hopkins University, and Institut Pasteur. His collaborative approach has strengthened the development of health strategies and infectious disease models that benefit multiple regions globally. Through these partnerships, Laurent has facilitated impactful research and global cooperation in combating vaccine-preventable diseases.
POLICYMAKER INTERACTIONS 🏛️
Laurent actively engages with policymakers, recommending bodies, and regulatory authorities to provide scientific evidence that influences vaccine recommendations and registrations. His input has been pivotal in shaping public health policies across the globe, ensuring that vaccination strategies are well-informed by rigorous research and statistical models, ultimately safeguarding public health.
EARLY CAREER IN RESEARCH 🏥
Prior to joining Sanofi, Laurent was a Senior Researcher at CRESGE, the research center of the Catholic University of Lille. There, he conducted economic studies related to drugs, vaccines, and healthcare systems. His work at CRESGE laid the foundation for his expertise in health economics and infectious disease modeling, contributing to both public and private healthcare sectors.
PUBLIC HEALTH CONTRIBUTIONS 🌟
Beyond his professional roles, Laurent’s dedication to public health is evident through his continuous research efforts and global collaborations. His work has not only advanced the scientific community’s understanding of disease transmission but has also played a crucial role in the fight against emerging infectious diseases. Laurent's achievements in vaccine modeling continue to have a lasting impact on health outcomes worldwide.
NOTABLE PUBLICATION
Title: Estimating the global burden of endemic canine rabies
Authors: K Hampson, L Coudeville, T Lembo, M Sambo, A Kieffer, M Attlan
Journal: PLoS Neglected Tropical Diseases
Year: 2015
Title: Economic impact of dengue illness in the Americas
Authors: DS Shepard, L Coudeville, YA Halasa, B Zambrano, GH Dayan
Journal: The American Journal of Tropical Medicine and Hygiene
Year: 2011
Title: Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a Bayesian random-effects model
Authors: L Coudeville, F Bailleux, B Riche, F Megas, P Andre, R Ecochard
Journal: BMC Medical Research Methodology
Year: 2010
Title: Health economics of dengue: a systematic literature review and expert panel's assessment
Authors: ME Beatty, P Beutels, MI Meltzer, DS Shepard, J Hombach, R Hutubessy
Journal: The American Journal of Tropical Medicine and Hygiene
Year: 2011
Title: The long-term safety, public health impact, and cost-effectiveness of routine vaccination with a recombinant, live-attenuated dengue vaccine (Dengvaxia): a model comparison study
Authors: S Flasche, M Jit, I Rodríguez-Barraquer, L Coudeville, M Recker, K Koelle
Journal: PLoS Medicine
Year: 2016